Molina Healthcare (MOH) reports director stock award of 317 shares

Rhea-AI Filing Summary

Molina Healthcare, Inc. reported that Director Richard C. Zoretic received a quarterly stock grant under the company’s 2025 Equity Incentive Plan for his board service. The award is part of an annual equity grant valued at $220,000 for each director, paid in four quarterly installments of $55,000.

For the quarter beginning January 1, 2026, the grant was set at 317 shares of common stock, calculated using the December 31, 2025 closing price of $173.54 because January 1 was a non-trading day. After this transaction, 7,947 shares of Molina Healthcare common stock are reported as beneficially owned indirectly through the Richard Charles Zoretic Revocable Living Trust.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider ZORETIC RICHARD C

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	317	$173.54	$55K

Holdings After Transaction: Common Stock — 7,947 shares (Indirect, Held by trust)

Footnotes (1)

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2026, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2025, of $173.54. Thus, the grant this quarter for services as a Director is for 317 shares of the Issuer's common stock. Represents the closing price of the Issuer's common stock on December 31, 2025. All shares held by the Richard Charles Zoretic Revocable Living Trust.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ZORETIC RICHARD C

(Last) (First) (Middle)

2180 HARVARD STREET

SUITE 400

(Street)

SACRAMENTO CA 95815

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/01/2026		A(1)		317(2)	A	$173.54(3)	7,947	I	Held by trust(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2026, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2025, of $173.54. Thus, the grant this quarter for services as a Director is for 317 shares of the Issuer's common stock.

3. Represents the closing price of the Issuer's common stock on December 31, 2025.

4. All shares held by the Richard Charles Zoretic Revocable Living Trust.

Remarks:

	Jeff D. Barlow, by power of attorney for Richard C. Zoretic	01/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction was reported for Molina Healthcare (MOH)?

A director received a quarterly grant of 317 shares of Molina Healthcare common stock under the company’s 2025 Equity Incentive Plan for board service.

What is the annual equity compensation for Molina Healthcare directors?

Each director’s annual equity award is valued at $220,000, delivered as four quarterly grants of $55,000 each, based on the stock’s closing price on the grant date.

How was the 317-share grant for Molina Healthcare’s director calculated?

The 317 shares were based on a quarterly award value of $55,000 divided by the $173.54 closing price of Molina Healthcare common stock on December 31, 2025.

Why was December 31, 2025 used as the pricing date for the Molina Healthcare grant?

Because the grant date of January 1, 2026 was a non-trading day, the company used the December 31, 2025 closing price of $173.54 to determine the number of shares.

How many Molina Healthcare shares does the reporting person now beneficially own?

Following the reported transaction, the director is shown as beneficially owning 7,947 shares of Molina Healthcare common stock, held indirectly through a revocable living trust.

In whose name are the Molina Healthcare shares held?

All reported shares are held by the Richard Charles Zoretic Revocable Living Trust, with the director reporting indirect beneficial ownership.